Neutralizing Viruses at the Source: Engineered Antibodies in Mosquitoes Offer New Hope Against Arbovirus Threats 08·05·2025
Precision Engineering of Nanobodies via Site-Specific Lysine Modification and KAT Ligation 24·04·2025
Cullinan Therapeutics Launches Phase 1 Trial of CD19 T Cell Engager CLN-978 for Rheumatoid Arthritis in Europe 18·04·2025